Status:
COMPLETED
Electronic Record Assimilation and Subsequent Eradication of Hepatitis C
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Gilead Sciences
Conditions:
Hepatitis C
Liver Diseases
Eligibility:
All Genders
54-74 years
Phase:
NA
Brief Summary
Given the disproportionately high risk of chronic hepatitis C virus (HCV) infection in the baby boomer cohort, population-based screening has been demonstrated cost effective. Compared to point-of-car...
Detailed Description
The Centers for Disease Control and Prevention (CDC) and the United States Preventative Services Taskforce (USPSTF) recommend a one-time hepatitis C infection (HCV) screen in individuals born 1945-65 ...
Eligibility Criteria
Inclusion
- persons born between 1945-1965
- having an activated patient portal to receive secure messages (MyHealth)
- no prior HCV antibody test within our EHR (electronic health record), including externally accessible results
Exclusion
- documented HCV viral load in our EHR
- diagnosis of chronic HCV in their problem list
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT04873609
Start Date
May 1 2019
End Date
April 30 2020
Last Update
September 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94305